[Drug-induced rhabdomyolysis]

Nihon Rinsho. 2007 Oct 28:65 Suppl 8:567-71.

[Article in Japanese]

Author

Shiro Ueda¹

Affiliation

¹ Department of Drug Information and Communication, Graduate School of Pharmaceutical Sciences, Chiba University.

PMID: 18072348

No abstract available

Publication types

Review

MeSH terms

Acute Kidney Injury / chemically induced
Anesthetics / adverse effects
Angiotensin II Type 1 Receptor Blockers / adverse effects
Anti-Infective Agents / adverse effects*
Anti-Ulcer Agents / adverse effects*
Antiparkinson Agents / adverse effects
Antipsychotic Agents / adverse effects
Glycyrrhizic Acid / adverse effects
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
Hypolipidemic Agents / adverse effects*
Immunosuppressive Agents / adverse effects
Malignant Hyperthermia / etiology
Rhabdomyolysis / chemically induced*
Rhabdomyolysis / diagnosis
Rhabdomyolysis / prevention & control
Rhabdomyolysis / therapy
Time Factors

Substances

Anesthetics
Angiotensin II Type 1 Receptor Blockers
Anti-Infective Agents
Anti-Ulcer Agents
Antiparkinson Agents
Antipsychotic Agents
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
Immunosuppressive Agents
Glycyrrhizic Acid